Sound Income Strategies’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-76
Closed -$17 1626
2024
Q4
$17 Hold
76
﹤0.01% 1445
2024
Q3
$163 Hold
76
﹤0.01% 1357
2024
Q2
$392 Hold
76
﹤0.01% 1298
2024
Q1
$407 Hold
76
﹤0.01% 1258
2023
Q4
$592 Hold
76
﹤0.01% 1221
2023
Q3
$300 Hold
76
﹤0.01% 1096
2023
Q2
$239 Hold
76
﹤0.01% 1069
2023
Q1
$203 Buy
+76
New +$295 ﹤0.01% 1032

Other funds holding SYRS

Sound Income Strategies's SYRS Position: Q1 2025 in Review

Sound Income Strategies sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q1 2025, closing a stake of 76 shares — an estimated $17 sold.

Sound Income Strategies first reported a position in SYRS in Q1 2023 and held it in 8 quarters. The position peaked at $592 in Q4 2023. 7 funds tracked by Wall St. Rank hold SYRS as of Q1 2025.

  • Sound Income Strategies reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Sound Income Strategies sold 76 Syros Pharmaceuticals, Inc. Common Stock shares in Q1 2025, an estimated $17.
  • Sound Income Strategies first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q1 2023 and held it in 8 quarters.
  • Sound Income Strategies's Syros Pharmaceuticals, Inc. Common Stock position peaked at $592 in Q4 2023.
  • 7 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q1 2025.

Based on Sound Income Strategies's 13F filing for Q1 2025, filed 17 Apr 2025.